The Dynamic Spillovers of Entry: An Application to the Generic Drug Industry
A. Ronald Gallant (),
Han Hong () and
Ahmed Khwaja ()
Additional contact information
A. Ronald Gallant: Pennsylvania State University, University Park, Pennsylvania 16802
Han Hong: Stanford University, Stanford, California 94305
Ahmed Khwaja: Judge Business School, University of Cambridge, Cambridge CB2 1AG, United Kingdom
Management Science, 2018, vol. 64, issue 3, 1189-1211
Abstract:
This paper examines whether experience from entry in one market can potentially enhance profitability at a future market opportunity for a related product. We formulate and estimate a dynamic game of entry in which forward-looking firms make decisions not just based on present benefits of past entry but also anticipating potential future benefits of current entry. Dynamic spillovers of entry are incorporated through a firm-specific unobservable (to the researcher) cost that depends on past entry decisions. The unobserved costs may also be serially persistent. Thus, the model allows for firm-specific unobserved heterogeneity that evolves based on firm actions. The challenge of estimating a dynamic game with serially correlated unobserved state variables subject to endogenous feedback is overcome by embedding a particle filter-based technique in a nested fixed-point algorithm. Using an application to a stylized model of entry in the generic pharmaceutical industry, we underscore the motivation for the model specification and the methodology developed. Our estimates imply positive spillover effects of entry. Moreover, these spillovers suggest heterogeneity not just across firms but also within firms over time based on their history of entry decisions. Our results illustrate that entry may potentially provide firms with additional strategic advantage in later markets and that entry spillovers may be an important factor to consider in the equilibrium evolution of the generic drug industry.
Keywords: dynamic discrete games; particle filter; unobserved state variables; endogenous feedback; serial correlation; dynamic entry; entry spillovers; generic pharmaceuticals (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)
Downloads: (external link)
https://doi.org/10.1287/mnsc.2016.2648 (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:inm:ormnsc:v:64:y:2018:i:3:p:1189-1211
Access Statistics for this article
More articles in Management Science from INFORMS Contact information at EDIRC.
Bibliographic data for series maintained by Chris Asher ().